Novo Holdings A/S 13D and 13G filings for Inozyme Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-07-30 4:31 pm Sale | 2021-07-26 | 13D | Inozyme Pharma, Inc. INZY | Novo Holdings A/S | 1,167,706 4.970% | -801,673 (-40.71%) | Filing |
| 2021-03-30 4:55 pm Sale | 2021-03-25 | 13D | Inozyme Pharma, Inc. INZY | Novo Holdings A/S | 1,969,379 8.400% | -225,000 (-10.25%) | Filing |
| 2021-02-01 4:31 pm Sale | 2021-01-28 | 13D | Inozyme Pharma, Inc. INZY | Novo Holdings A/S | 2,194,379 9.400% | -375,000 (-14.59%) | Filing |
| 2020-10-05 4:45 pm Unchanged | 2020-09-30 | 13D | Inozyme Pharma, Inc. INZY | Novo Holdings A/S | 2,569,379 11.000% | 0 (Unchanged) | Filing |
| 2020-07-29 4:42 pm Purchase | 2020-07-28 | 13D | Inozyme Pharma, Inc. INZY | Novo Holdings A/S | 2,569,379 11.500% | 2,569,379 (New Position) | Filing |